Dr. Bray Links

Saturday, April 2, 2016

ZdoggMD takes an anti-anti-vaccine stance

ZdoggMD has entertained many healthcare providers with his videos like EHR State of Mind and Readmission. In his latest video, he takes an anti-anti-vaccine stance. Unfortunately, he does so from a staunchly paternalistic position which provides little support. After listening to the video, one might walk away with the conviction that "100% of vaccines are safe 100% of the time". However, the classic paternalism strategy doesn't seem to work well anymore in today's world where quality information is freely accessible. This classic strategy entails vocalizing: 1) I'm the intelligent, well-educated, well-researched physician, 2) You're the low IQ, poorly-educated, poorly-researched patient, and 3) If you disagree with me, you are a crazy person and should be humiliated. In this classic strategy, no legitimate references are provided for the authoritarian position except to make fun of patients using their ridiculous sources (like Dr. Google).

The truth is that many patients are now using PubMed and peer-reviewed medical articles to make decisions about their healthcare. They are critiquing the biases contained within research studies and the conflicts of interest among the authors. They are paying attention to and "biohacking" their own body more than any physician has the time to fully consider and process. Some patients have legitimately been injured by vaccines (as judged by conventional independent physicians). That is the reason that the U.S. Department of Health and Human Services created the Vaccine Injury Compensation Program (VICP). This program has paid out $3.3 billion since its inception. A little humility would certainly open Dr. Zubin Damania's eyes to the fact that at best "most vaccines are mostly safe".

Instead of swirling around in the clouds with catchy music videos, read through these publications:

1: Gromeier M, Wimmer E. Mechanism of injury-provoked poliomyelitis. J Virol.
1998 Jun;72(6):5056-60. PubMed PMID: 9573275; PubMed Central PMCID: PMC110068.

2: Ridgway D. No-fault vaccine insurance: lessons from the National Vaccine
Injury Compensation Program. J Health Polit Policy Law. 1999 Feb;24(1):59-90.
Review. PubMed PMID: 10342255.

3: Exley C, Swarbrick L, Gherardi RK, Authier FJ. A role for the body burden of
aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue
syndrome. Med Hypotheses. 2009 Feb;72(2):135-9. doi: 10.1016/j.mehy.2008.09.040.
Epub 2008 Nov 11. PubMed PMID: 19004564.

4: Weibel RE, Benor DE. Chronic arthropathy and musculoskeletal symptoms
associated with rubella vaccines. A review of 124 claims submitted to the
National Vaccine Injury Compensation Program. Arthritis Rheum. 1996
Sep;39(9):1529-34. Erratum in: Arthritis Rheum 1996 Nov;39(11):1930. PubMed PMID:

5: Weibel RE, Caserta V, Benor DE, Evans G. Acute encephalopathy followed by
permanent brain injury or death associated with further attenuated measles
vaccines: a review of claims submitted to the National Vaccine Injury
Compensation Program. Pediatrics. 1998 Mar;101(3 Pt 1):383-7. PubMed PMID:

6: Ellenberg SS, Chen RT. The complicated task of monitoring vaccine safety.
Public Health Rep. 1997 Jan-Feb;112(1):10-20; discussion 21. Review. PubMed PMID:
9018282; PubMed Central PMCID: PMC1381831.

7: Yuji K, Nakada H. Compensation programs after withdrawal of the recommendation
for HPV vaccine in Japan. Hum Vaccin Immunother. 2015 Oct 29:1-4. [Epub ahead of
print] PubMed PMID: 26513303.

8: Follows J. Vaccine adverse events. Workplace Health Saf. 2012 Jan;60(1):7-10.
doi: 10.3928/21650799-20111227-13. PubMed PMID: 22233593.

9: Choe YJ, Cho H, Bae GR, Lee JK. Guillain-Barré syndrome following receipt of
influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton
Collaboration case definition. Vaccine. 2011 Mar 3;29(11):2066-70. doi:
10.1016/j.vaccine.2011.01.007. Epub 2011 Jan 19. PubMed PMID: 21255684.

10: Trollfors B, Bergfors E. [Aluminum allergy following vaccination should be
entitled to compensation as drug-induced injury]. Lakartidningen. 2007 May
9-15;104(19):1533-4; author reply 1534. Swedish. PubMed PMID: 17550036.

11: Geier DA, Kern JK, Hooker BS, Sykes LK, Geier MR. Thimerosal-Preserved
Hepatitis B Vaccine and Hyperkinetic Syndrome of Childhood. Brain Sci. 2016 Mar
15;6(1). pii: E9. doi: 10.3390/brainsci6010009. PubMed PMID: 26999226.

12: Glanz JM, Newcomer SR, Daley MF, McClure DL, Baxter RP, Jackson ML, Naleway
AL, Lugg MM, DeStefano F. Cumulative and episodic vaccine aluminum exposure in a
population-based cohort of young children. Vaccine. 2015 Nov 27;33(48):6736-44.
doi: 10.1016/j.vaccine.2015.10.076. Epub 2015 Oct 27. PubMed PMID: 26518400.

13: Geier DA, Kern JK, Hooker BS, King PG, Sykes LK, Geier MR. A longitudinal
cohort study of the relationship between Thimerosal-containing hepatitis B
vaccination and specific delays in development in the United States: Assessment
of attributable risk and lifetime care costs. J Epidemiol Glob Health. 2015 Jul
9. pii: S2210-6006(15)00064-7. doi: 10.1016/j.jegh.2015.06.002. [Epub ahead of
print] PubMed PMID: 26166425.

14: Dórea JG. Exposure to mercury and aluminum in early life: developmental
vulnerability as a modifying factor in neurologic and immunologic effects. Int J
Environ Res Public Health. 2015 Jan 23;12(2):1295-313. doi:
10.3390/ijerph120201295. PubMed PMID: 25625408; PubMed Central PMCID: PMC4344667.

15: Geier DA, Kern JK, Hooker BS, King PG, Sykes LK, Geier MR.
Thimerosal-containing hepatitis B vaccination and the risk for diagnosed specific
delays in development in the United States: a case-control study in the vaccine
safety datalink. N Am J Med Sci. 2014 Oct;6(10):519-31. doi:
10.4103/1947-2714.143284. PubMed PMID: 25489565; PubMed Central PMCID:

16: Geier DA, Kern JK, King PG, Sykes LK, Geier MR. A case-control study
evaluating the relationship between thimerosal-containing haemophilus influenzae
type b vaccine administration and the risk for a pervasive developmental disorder
diagnosis in the United States. Biol Trace Elem Res. 2015 Feb;163(1-2):28-38.
doi: 10.1007/s12011-014-0169-3. Epub 2014 Nov 11. PubMed PMID: 25382662; PubMed
Central PMCID: PMC4297306.

17: Geier DA, Hooker BS, Kern JK, King PG, Sykes LK, Geier MR. A dose-response
relationship between organic mercury exposure from thimerosal-containing vaccines
and neurodevelopmental disorders. Int J Environ Res Public Health. 2014 Sep
5;11(9):9156-70. doi: 10.3390/ijerph110909156. PubMed PMID: 25198681; PubMed
Central PMCID: PMC4199012.

18: Gherardi RK, Aouizerate J, Cadusseau J, Yara S, Authier FJ. Aluminum
adjuvants of vaccines injected into the muscle: Normal fate, pathology and
associated disease. Morphologie. 2016 Mar 2. pii: S1286-0115(16)00025-4. doi:
10.1016/j.morpho.2016.01.002. [Epub ahead of print] Review. PubMed PMID:

19: Petrovsky N. Comparative Safety of Vaccine Adjuvants: A Summary of Current
Evidence and Future Needs. Drug Saf. 2015 Nov;38(11):1059-74. doi:
10.1007/s40264-015-0350-4. PubMed PMID: 26446142; PubMed Central PMCID:

20: Pasquale AD, Preiss S, Silva FT, Garçon N. Vaccine Adjuvants: from 1920 to
2015 and Beyond. Vaccines (Basel). 2015 Apr 16;3(2):320-43. doi:
10.3390/vaccines3020320. Review. PubMed PMID: 26343190; PubMed Central PMCID:

21: Guimarães LE, Baker B, Perricone C, Shoenfeld Y. Vaccines, adjuvants and
autoimmunity. Pharmacol Res. 2015 Oct;100:190-209. doi:
10.1016/j.phrs.2015.08.003. Epub 2015 Aug 12. Review. PubMed PMID: 26275795.

22: Ahmed SS, Steinman L. Mechanistic Insights into Influenza Vaccine-Associated
Narcolepsy. Hum Vaccin Immunother. 2016 Mar 31:0. [Epub ahead of print] PubMed
PMID: 27031682.

23: Baker B, Eça Guimarães L, Tomljenovic L, Agmon-Levin N, Shoenfeld Y. The
safety of human papilloma virus-blockers and the risk of triggering autoimmune
diseases. Expert Opin Drug Saf. 2015;14(9):1387-94. doi:
10.1517/14740338.2015.1073710. Epub 2015 Jul 28. PubMed PMID: 26216756.

24: Pellegrino P, Clementi E, Radice S. On vaccine's adjuvants and autoimmunity:
Current evidence and future perspectives. Autoimmun Rev. 2015 Oct;14(10):880-8.
doi: 10.1016/j.autrev.2015.05.014. Epub 2015 May 29. Review. PubMed PMID:

25: Alijotas-Reig J. Human adjuvant-related syndrome or autoimmune/inflammatory
syndrome induced by adjuvants. Where have we come from? Where are we going? A
proposal for new diagnostic criteria. Lupus. 2015 Sep;24(10):1012-8. doi:
10.1177/0961203315579092. Epub 2015 Mar 25. PubMed PMID: 25813870.

26: van der Laan JW, Gould S, Tanir JY; ILSI HESI Vaccines and Adjuvants Safety
Project Committee. Safety of vaccine adjuvants: focus on autoimmunity. Vaccine.
2015 Mar 24;33(13):1507-14. doi: 10.1016/j.vaccine.2015.01.073. Epub 2015 Feb 7.
PubMed PMID: 25659277.

27: Butnaru D, Shoenfeld Y. Adjuvants and lymphoma risk as part of the ASIA
spectrum. Immunol Res. 2015 Feb;61(1-2):79-89. doi: 10.1007/s12026-014-8622-0.
Review. PubMed PMID: 25582758.

28: Cheng MP, Kozoriz MG, Ahmadi AA, Kelsall J, Paquette K, Onrot JM.
Post-vaccination myositis and myocarditis in a previously healthy male. Allergy
Asthma Clin Immunol. 2016 Feb 11;12:6. doi: 10.1186/s13223-016-0114-4.
eCollection 2016. PubMed PMID: 26877725; PubMed Central PMCID: PMC4751718.

29: Esposito S, Prada E, Mastrolia MV, Tarantino G, Codecà C, Rigante D.
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): clues and pitfalls
in the pediatric background. Immunol Res. 2014 Dec;60(2-3):366-75. doi:
10.1007/s12026-014-8586-0. Review. PubMed PMID: 25395340.

30: Pellegrino P, Perrone V, Pozzi M, Carnovale C, Perrotta C, Clementi E, Radice
S. The epidemiological profile of ASIA syndrome after HPV vaccination: an
evaluation based on the Vaccine Adverse Event Reporting Systems. Immunol Res.
2015 Feb;61(1-2):90-6. doi: 10.1007/s12026-014-8567-3. PubMed PMID: 25381482.

31: Colafrancesco S, Perricone C, Priori R, Valesini G, Shoenfeld Y. Sjögren's
syndrome: another facet of the autoimmune/inflammatory syndrome induced by
adjuvants (ASIA). J Autoimmun. 2014 Jun;51:10-6. doi: 10.1016/j.jaut.2014.03.003.
Epub 2014 Apr 26. Review. PubMed PMID: 24774584.

32: Soriano A. The paradigm of ASIA (autoimmune/inflammatory syndrome induced by
adjuvants): a concept in evolution. Isr Med Assoc J. 2014 Feb;16(2):113-4. PubMed
PMID: 24645232.

33: Pineda JC, Díaz JC, Agualimpia A, García JF. Autoimmune/inflammatory syndrome
induced by adjuvants causing myositis and pulmonary fibrosis. Isr Med Assoc J.
2013 Nov;15(11):720-1. PubMed PMID: 24511658.

34: Cruz-Domínguez MP, Vera-Lastra O, Deras-Quiñones A, Jandete-Rivera F,
Grajeda-Lopez P, Montes-Cortes DH, Medina G, Jara LJ. Mercury tissue deposits: a
new adjuvant in autoimmune/inflammatory syndrome. Isr Med Assoc J. 2013
Nov;15(11):716-9. PubMed PMID: 24511657.

35: Perricone C, Colafrancesco S, Mazor RD, Soriano A, Agmon-Levin N, Shoenfeld
Y. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling
the pathogenic, clinical and diagnostic aspects. J Autoimmun. 2013 Dec;47:1-16.
doi: 10.1016/j.jaut.2013.10.004. Epub 2013 Nov 13. Review. PubMed PMID: 24238833.

36: Colafrancesco S, Perricone C, Tomljenovic L, Shoenfeld Y. Human papilloma
virus vaccine and primary ovarian failure: another facet of the
autoimmune/inflammatory syndrome induced by adjuvants. Am J Reprod Immunol. 2013
Oct;70(4):309-16. doi: 10.1111/aji.12151. Epub 2013 Jul 31. Review. PubMed PMID:

37: Perricone C, Shoenfeld Y. Hepatitis B vaccination and undifferentiated
connective tissue disease: another brick in the wall of the
autoimmune/inflammatory syndrome induced by adjuvants (Asia). J Clin Rheumatol.
2013 Aug;19(5):231-3. doi: 10.1097/RHU.0b013e31829d56f1. PubMed PMID: 23884184.

38: Cerpa-Cruz S, Paredes-Casillas P, Landeros Navarro E, Bernard-Medina AG,
Martínez-Bonilla G, Gutiérrez-Ureña S. Adverse events following immunization with
vaccines containing adjuvants. Immunol Res. 2013 Jul;56(2-3):299-303. doi:
10.1007/s12026-013-8400-4. PubMed PMID: 23576057.

39: Vera-Lastra O, Medina G, Cruz-Dominguez Mdel P, Jara LJ, Shoenfeld Y.
Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome):
clinical and immunological spectrum. Expert Rev Clin Immunol. 2013
Apr;9(4):361-73. doi: 10.1586/eci.13.2. Review. PubMed PMID: 23557271.

40: Lerner A. Aluminum as an adjuvant in Crohn's disease induction. Lupus. 2012
Feb;21(2):231-8. doi: 10.1177/0961203311430090. PubMed PMID: 22235058.

41: Perdan-Pirkmajer K, Thallinger GG, Snoj N, Čučnik S, Žigon P, Kveder T, Logar
D, Praprotnik S, Tomšič M, Sodin-Semrl S, Ambrožič A. Autoimmune response
following influenza vaccination in patients with autoimmune inflammatory
rheumatic disease. Lupus. 2012 Feb;21(2):175-83. doi: 10.1177/0961203311429817.
PubMed PMID: 22235050.

42: Soriano A, Verrecchia E, Marinaro A, Giovinale M, Fonnesu C, Landolfi R,
Manna R. Giant cell arteritis and polymyalgia rheumatica after influenza
vaccination: report of 10 cases and review of the literature. Lupus. 2012
Feb;21(2):153-7. doi: 10.1177/0961203311430222. Review. PubMed PMID: 22235046.

43: Rosenblum H, Shoenfeld Y, Amital H. The common immunogenic etiology of
chronic fatigue syndrome: from infections to vaccines via adjuvants to the ASIA
syndrome. Infect Dis Clin North Am. 2011 Dec;25(4):851-63. doi:
10.1016/j.idc.2011.07.012. Epub 2011 Sep 9. Review. PubMed PMID: 22054760.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.